Author | Patients | Mean age(year) | Interventions | ARCO classification | Pathogenesis(hips) | Follow-up time(m) | Post-HHS | THA | Complications |
---|---|---|---|---|---|---|---|---|---|
Shen et al. 2021 [23] | 53 | 31.7(13–52) | SHD + Iliac bone grafts | II, III | Steroid 24 Alcohol 14 Trauma 9 Idiopathic 6 | 20(8–38) | 83.2 ± 5.8 | 2 | 0 |
Liang et al. 2021 [24] | 28 | 36.25(21–53) | SHD + Iliac bone grafts | II, III | Steroid 12 Alcohol 10 Idiopathic 6 | 24.29 | 87.07 ± 1.69 | 3 | 1 |
Tang et al. 2020 [25] | 26 | 36.2(21–53) | SHD + PRP | II, III | Steroid 15 Alcohol 8 Idiopathic 3 | 36.6(26–42) | 87.38 ± 8.21 | 1 | 1 |
Steppacher et al. 2020 [26] | 13 | 29(20–49) | SHD | II, III | Steroid 4 Trauma 1 Idiopathic 8 | 36(12–84) | Nonea | 1 | 2 |
Wei et al. 2020 [17] | 32 | 27.6(18–49) | SHD + Iliac bone grafts | III | Steroid 18 Alcohol 5 Trauma 4 Idiopathic 5 | 41.0(29–51) | 82.1 ± 4.6 | 1 | 0 |
Xia et al. 2020 [18] | 33 | 31.7(19–46) | SHD | III | Non-traumatic | 18(12–28) | 81.50 ± 8.81 | 1 | 0 |
Zheng et al. 2020 [27] | 15 | 32.3(23–50) | SHD + Iliac bone grafts | III | None | 15.3(9 ~ 30) | 83.75 ± 7.62 | 0 | 0 |
Du et al. 2019 [28] | 15 | 32.76(17–46) | SHD + TCM | III | None | 14.60(6 ~ 25) | 74.37 ± 6.46 | 0 | 0 |
Sun et al. 2019 [16] | 28 | 35.7(18–45) | SHD | III | Steroid 15 Alcohol 9 Idiopathic 4 | 25.8(12–48) | 88.74 ± 1.68 | 5 | 1 |
Deng et al. 2018 [29] | 43 | 36.8 | SHD | II | None | 21.8(14–36) | 89.89 ± 8.13 | 0 | 0 |
Liu et al. 2018 [30] | 22 | 34.3 | SHD + PRP | II, III | Non-traumatic | 12.40 | 86.84 ± 6.44 | 0 | 0 |
Zhuang et al. 2017 [19] | 22 | 38.8(29–46) | SHD + TCM | III | Steroid 4 Alcohol 16 Trauma 2 | 11.8(6–18) | 91.0 ± 6.3 | 0 | 0 |
Yao et al. 2017 [15] | 8 | 36(26–44) | SHD | III | Steroid 3 Alcohol 4 Trauma 1 | 18.6(5–29) | 80.53 ± 7.62 | 1 | 1 |
Chen et al. 2022 | 34 | 22.18(12–30) | SHD + Iliac bone grafts | III, IV | Steroid 10 Alcohol 16 Trauma 9 Idiopathic 3 | 40.77(22.33–74.07) | 86.76 ± 10.22 | 3 | 0 |